HIV Infections
Conditions
Keywords
Delayed-Action Preparations, Disulfiram, Acquired Immunodeficiency Syndrome, AIDS-Related Complex
Brief summary
To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
Interventions
DRUGDisulfiram
Sponsors
St. Vincent's Medical Center
Study design
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria. * Also patient must be: * Able to understand the study. * Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms. * Ambulatory and able to maintain an independent life outside the hospital. * Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. History of alcohol abuse.
Countries
United States
Outcome results
None listed